273 related articles for article (PubMed ID: 38419010)
21. Treatment of recurrent Clostridioides difficile infections with faecal microbiota transplantation: peri-procedural methods in a consecutive case series.
Korpak K; Defourny L; Lali S; Delvallée M; Demeester R; Toussaint E
Acta Gastroenterol Belg; 2023; 86(3):486-489. PubMed ID: 37814565
[TBL] [Abstract][Full Text] [Related]
22. Long-term effects on luminal and mucosal microbiota and commonly acquired taxa in faecal microbiota transplantation for recurrent Clostridium difficile infection.
Jalanka J; Mattila E; Jouhten H; Hartman J; de Vos WM; Arkkila P; Satokari R
BMC Med; 2016 Oct; 14(1):155. PubMed ID: 27724956
[TBL] [Abstract][Full Text] [Related]
23. Factors Related to Outcomes of Fecal Microbiota Transplantation in Patients with
Yoon H; Shim HI; Seol M; Shin CM; Park YS; Kim N; Lee DH
Gut Liver; 2021 Jan; 15(1):61-69. PubMed ID: 32839363
[TBL] [Abstract][Full Text] [Related]
24. Microbiome changes associated with sustained eradication of Clostridium difficile after single faecal microbiota transplantation in children with and without inflammatory bowel disease.
Hourigan SK; Chen LA; Grigoryan Z; Laroche G; Weidner M; Sears CL; Oliva-Hemker M
Aliment Pharmacol Ther; 2015 Sep; 42(6):741-52. PubMed ID: 26198180
[TBL] [Abstract][Full Text] [Related]
25. Bacterial microbiome changes after fecal transplantation for recurrent Clostridioides difficile infection in the Brazilian center.
Terra DAA; de Oliveira Carvalho RD; da Silva TF; Dos Santos Freitas A; Góes-Neto A; Amarante VS; Azevedo V; Vilela EG; Coelho LGV; Silva ROS
Braz J Microbiol; 2024 Mar; 55(1):719-725. PubMed ID: 38158466
[TBL] [Abstract][Full Text] [Related]
26. Fecal Microbiota Transplantation Increases Colonic IL-25 and Dampens Tissue Inflammation in Patients with Recurrent Clostridioides difficile.
Jan N; Hays RA; Oakland DN; Kumar P; Ramakrishnan G; Behm BW; Petri WA; Marie C
mSphere; 2021 Oct; 6(5):e0066921. PubMed ID: 34704776
[TBL] [Abstract][Full Text] [Related]
27. Transmission and clearance of potential procarcinogenic bacteria during fecal microbiota transplantation for recurrent Clostridioides difficile.
Drewes JL; Corona A; Sanchez U; Fan Y; Hourigan SK; Weidner M; Sidhu SD; Simner PJ; Wang H; Timp W; Oliva-Hemker M; Sears CL
JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31578306
[TBL] [Abstract][Full Text] [Related]
28. Long-term durability and safety of fecal microbiota transplantation for recurrent or refractory Clostridioides difficile infection with or without antibiotic exposure.
Lee CH; Chai J; Hammond K; Jeon SR; Patel Y; Goldeh C; Kim P
Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1731-1735. PubMed ID: 31165961
[TBL] [Abstract][Full Text] [Related]
29. Improving Risk-Benefit in Faecal Transplantation through Microbiome Screening.
Papanicolas LE; Gordon DL; Wesselingh SL; Rogers GB
Trends Microbiol; 2020 May; 28(5):331-339. PubMed ID: 31952909
[TBL] [Abstract][Full Text] [Related]
30. Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial.
Kelly CR; Khoruts A; Staley C; Sadowsky MJ; Abd M; Alani M; Bakow B; Curran P; McKenney J; Tisch A; Reinert SE; Machan JT; Brandt LJ
Ann Intern Med; 2016 Nov; 165(9):609-616. PubMed ID: 27547925
[TBL] [Abstract][Full Text] [Related]
31. Successful therapy of Clostridium difficile infection with fecal microbiota transplantation.
Konturek PC; Koziel J; Dieterich W; Haziri D; Wirtz S; Glowczyk I; Konturek K; Neurath MF; Zopf Y
J Physiol Pharmacol; 2016 Dec; 67(6):859-866. PubMed ID: 28195066
[TBL] [Abstract][Full Text] [Related]
32. [Reconsidering the technical aspects and quality management background of faecal microbiota transplantation due to the novel coronavirus pandemic].
Nagy GG; Tudlik Z; Gergely L; Kónya J; Orosi P; Rákóczi É; Szabó J; Várvölgyi C; Vitális E; Paragh G
Orv Hetil; 2020 Nov; 161(44):1858-1871. PubMed ID: 33130602
[TBL] [Abstract][Full Text] [Related]
33. Faecalibacterium prausnitzii increases following fecal microbiota transplantation in recurrent Clostridioides difficile infection.
Björkqvist O; Rangel I; Serrander L; Magnusson C; Halfvarson J; Norén T; Bergman-Jungeström M
PLoS One; 2021; 16(4):e0249861. PubMed ID: 33836037
[TBL] [Abstract][Full Text] [Related]
34. The evaluation of fecal microbiota transplantation vs vancomycin in a Clostridioides difficile infection model.
Xu Q; Zhang S; Quan J; Wu Z; Gu S; Chen Y; Zheng B; Lv L; Li L
Appl Microbiol Biotechnol; 2022 Oct; 106(19-20):6689-6700. PubMed ID: 36085529
[TBL] [Abstract][Full Text] [Related]
35. Changes in IgA-targeted microbiota following fecal transplantation for recurrent
Huus KE; Frankowski M; Pučić-Baković M; Vučković F; Lauc G; Mullish BH; Marchesi JR; Monaghan TM; Kao D; Finlay BB
Gut Microbes; 2021; 13(1):1-12. PubMed ID: 33382360
[TBL] [Abstract][Full Text] [Related]
36. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
[TBL] [Abstract][Full Text] [Related]
37. Predicting recurrence of Clostridium difficile infection following encapsulated fecal microbiota transplantation.
Staley C; Kaiser T; Vaughn BP; Graiziger CT; Hamilton MJ; Rehman TU; Song K; Khoruts A; Sadowsky MJ
Microbiome; 2018 Sep; 6(1):166. PubMed ID: 30227892
[TBL] [Abstract][Full Text] [Related]
38. Colonization potential to reconstitute a microbe community in patients detected early after fecal microbe transplant for recurrent C. difficile.
Kumar R; Maynard CL; Eipers P; Goldsmith KT; Ptacek T; Grubbs JA; Dixon P; Howard D; Crossman DK; Crowley MR; Benjamin WH; Lefkowitz EJ; Weaver CT; Rodriguez JM; Morrow CD
BMC Microbiol; 2016 Jan; 16():5. PubMed ID: 26758906
[TBL] [Abstract][Full Text] [Related]
39. Fecal Microbiome Transplantation for Recurrent Clostridioides difficile Infection: Treatment Efficacy, Short and Long-term Follow-up Results from Consecutive Case Series.
Urbonas T; Ianiro G; Gedgaudas R; Sabanas P; Urba M; Kiudelis V; Kiudelis G; Petkevicius V; Vitkauskiene A; Cammarota G; Gasbarrini A; Kupcinskas J
J Gastrointestin Liver Dis; 2021 Dec; 30(4):470-476. PubMed ID: 34752587
[TBL] [Abstract][Full Text] [Related]
40. Microbial taxonomic and metabolic alterations during faecal microbiota transplantation to treat Clostridium difficile infection.
Kellingray L; Gall GL; Defernez M; Beales ILP; Franslem-Elumogo N; Narbad A
J Infect; 2018 Aug; 77(2):107-118. PubMed ID: 29746938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
